MicroPort Endovascular MedTech Ltd
Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, and sale of aortic and peripheral vascular medical devices in China and internationally. The company offers branched aortic, thoracic, and bifurcated stent graft system; abdominal aortic stent graft and delivery system; and other stent graft system in surgical operation; as well as accessorie… Read more
MicroPort Endovascular MedTech Ltd (688016) - Total Liabilities
Latest total liabilities as of September 2025: CN¥750.07 Million CNY
Based on the latest financial reports, MicroPort Endovascular MedTech Ltd (688016) has total liabilities worth CN¥750.07 Million CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
MicroPort Endovascular MedTech Ltd - Total Liabilities Trend (2016–2024)
This chart illustrates how MicroPort Endovascular MedTech Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
MicroPort Endovascular MedTech Ltd Competitors by Total Liabilities
The table below lists competitors of MicroPort Endovascular MedTech Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Great Lakes Dredge & Dock
NASDAQ:GLDD
|
USA | $765.63 Million |
|
EVN AG
VI:EVN
|
Austria | €4.44 Billion |
|
Pigeon Corporation
F:9N3
|
Germany | €24.75 Billion |
|
Hypera S.A
SA:HYPE3
|
Brazil | R$16.27 Billion |
|
Genimous Technology Co Ltd
SHE:000676
|
China | CN¥679.40 Million |
|
Runjian Communication Co Ltd Class A
SHE:002929
|
China | CN¥15.18 Billion |
|
Anhui Guangxin Agrochemical Co Ltd
SHG:603599
|
China | CN¥5.12 Billion |
|
Societatea Nationala de Gaze Naturale Romgaz SA GDR (Sponsored) Reg S
PINK:SLTQY
|
USA | $5.75 Billion |
Liability Composition Analysis (2016–2024)
This chart breaks down MicroPort Endovascular MedTech Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.75 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.19 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.16 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how MicroPort Endovascular MedTech Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for MicroPort Endovascular MedTech Ltd (2016–2024)
The table below shows the annual total liabilities of MicroPort Endovascular MedTech Ltd from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥469.13 Million | +22.60% |
| 2023-12-31 | CN¥382.63 Million | +51.54% |
| 2022-12-31 | CN¥252.49 Million | +9.08% |
| 2021-12-31 | CN¥231.47 Million | +62.90% |
| 2020-12-31 | CN¥142.09 Million | +58.34% |
| 2019-12-31 | CN¥89.74 Million | +70.41% |
| 2018-12-31 | CN¥52.66 Million | +45.29% |
| 2017-12-31 | CN¥36.24 Million | -44.43% |
| 2016-12-31 | CN¥65.22 Million | -- |